IRE is not a universal treatment. It is occasionally considered within structured pathways for specific situations in prostate, pancreatic, liver and kidney disease. The pages below describe typical contexts in general terms.
Focal treatment strategies for carefully selected localised cancer, alongside whole-gland options.
Locally advanced disease and the role of multidisciplinary planning.
Primary and secondary liver lesions near critical structures.
Small renal masses where anatomy makes other ablative options difficult.
You can ask for a second opinion on imaging, diagnosis and treatment options before you decide.